Your SlideShare is downloading. ×
Radiopharmaceuticals Market Is Expected to Reach USD 12.2 Billion in 2018: Transparency Market Research
Upcoming SlideShare
Loading in...5

Thanks for flagging this SlideShare!

Oops! An error has occurred.


Introducing the official SlideShare app

Stunning, full-screen experience for iPhone and Android

Text the download link to your phone

Standard text messaging rates apply

Radiopharmaceuticals Market Is Expected to Reach USD 12.2 Billion in 2018: Transparency Market Research


Published on

According to a new market report published by Transparency Market Research, "Radiopharmaceuticals Market - Global Industry Analysis, Size, Share, Trends and Forecast, 2012 - 2018," the global market …

According to a new market report published by Transparency Market Research, "Radiopharmaceuticals Market - Global Industry Analysis, Size, Share, Trends and Forecast, 2012 - 2018," the global market for radiopharmaceuticals was valued at approximately USD 3.8 billion in 2011 and is expected to reach USD 12.2 billion by 2018 at a CAGR of 18.3% from 2012 to 2018. North America led the global radiopharmaceuticals market with the highest market share as Canada continues to be the largest exporter of uranium and nuclear technology, forming the backbone of nuclear medicine and imaging studies.

To Buy And Browse Full Report With TOC at :

Published in: Health & Medicine, Business

  • Be the first to comment

  • Be the first to like this

No Downloads
Total Views
On Slideshare
From Embeds
Number of Embeds
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

No notes for slide


  • 1. REPORT DESCRIPTIONRadiopharmaceuticals Market - Global Industry Analysis, Size, Share, Trends AndForecast, 2012 - 2018The Radiopharmaceuticals imply the usage of radiation for non-invasive treatment anddiagnosis of various diseases. Utilization of these molecules for medical purposes in PET andSPECT imaging has changed the entire algorithm of disease diagnosis. With rise in the agingpopulation globally coupled with increasing rate of chronic cardiovascular, oncology andneurology diseases, there is tremendous growth potential in this market, especially indeveloping nations. Similarly, the use of radiolabeled isotopes with peptides and monoclonalantibodies has opened new boulevards for the growth of the global radiopharmaceuticalsmarket. Many radiopharmaceuticals use technetium-99m (Tc-99m) that has many usefulproperties of gamma-emitting tracer nuclide.Radiopharmaceuticals are majorly used to diagnose cancer, tumors, biliary tract blockage,bone diseases, bone marrow diseases, brain diseases, colorectal disease, disorders of ironmetabolism and absorption, heart disease, heart muscle damage (infarct), impaired flow ofcerebrospinal fluid in the brain, kidney diseases, liver diseases, lung diseases, parathyroidTransparency Market ResearchRadiopharmaceuticalsMarket - Global IndustryAnalysis, Size, Share,Trends And Forecast, 2012- 2018Single User License: US $ 5595Multi User License: US $ 8595Corporate User License: US $ 11595Buy NowRequest SamplePublished Date: Feb 2013119 Pages Report
  • 2. diseases, parathyroid cancer, pernicious anemia, improper absorption of vitamin B12 fromintestines, red blood cell diseases, salivary gland diseases, spleen diseases, stomach andBrowse Report : Radiopharmaceuticals Marketintestinal bleeding, stomach problems, tear duct blockage, thyroid diseases, thyroid cancerand urinary bladder diseases.This may be given to the patient in a number of ways, for e.g. they may be given throughthe mouth, through injections or placed into the eye or into the bladder. It is a smalltreatment, which includes use of simple substances containing radioactive isotopes. Whiletreating cancer, these radioactive agents are taken up in the cancerous area to destroy theaffected tissues. It works effectively by targeting the areas in the body where the cancer ispresent. Individuals are suggested to intake radiopharmaceuticals only under the directsupervision of a doctor.This report analyses the global scenario of the radiopharmaceuticals market, discussingdetailed overview and market figures. The research report analyses the industry growthrate, industry capacity, and industry structure. The report analyses the historical data, andforecasts the radiopharmaceuticals market size, production forecasts along with key factorsdriving and restraining the market.The report also analyzes the radiopharmaceuticals market by generators and by furtherclassifying them in terms of medical isotopes, their applications, end users and geographicdistribution. The medical isotopes category covers major isotopes used in SPECT and PETimaging like technetium, thallium, gallium, rhenium, yttrium and others. The applicationsmarket is further classified into diagnosis and therapy. The end user analysis is done bybifurcation of the market into hospitals and outpatient diagnostic centers.The geography market has been segmented into four major regions - North America,Europe, Asia-Pacific and Rest of the World (RoW). Some of the top radiopharmaceuticalcompanies in the healthcare market are Covidien Plc, Nordion Inc., Lantheus MedicalImaging, IBA Group, Positron Corporation, Cardinal Health, Eckert & Ziegler among others.The study presents a comprehensive assessment of the stakeholder strategies, winningimperatives for them by segmenting the radiopharmaceuticals market as below:Radiopharmaceuticals Market by Generator Types Mo-99/Tc-99m generator Sr-82/Rb-82 generator Ge-68/Ga-68 generator Sr-90/Y-90 generator W-188/Re-188 generator
  • 3. Browse Report : Market by End-Users Hospitals & Medical Centers Diagnostic CentersRadiopharmaceuticals Market by Applications Diagnosis Diagnosis by Techniqueo SPECT Technetium (Tc-99m) Thallium (TI-201) Gallium (Ga-67) Iodine (I-123) Rhenium (Re-186) Yttrium (Y-90) Others/li>o PET Fludeoxyglucose (18F-FDG) Rubidium (Rb-82) Others (Carbon-11 choline, Nitrogen-13 ammonia)Diagnosis by Indications Oncology Cardiovascular Others (Neurological, Thyroid, Gastrointestinal)Therapy Systemic Oncology
  • 4. o Iodine (I-131)o Yttrium (90Y)o Samarium (Sm-153)o Strontium (89Sr)o Rhenium (186Re)o Lutetium (Lu-177)o Erbium (169Er)o Others Others (Cardiology, Neurology)Radiopharmaceuticals Market by Geography North America Europe Asia-Pacific Rest of the World (RoW)TABLE OF CONTENTSChapter 1 Preface1.1 Report Description1.2 Market Segmentation1.3 Research MethodologyChapter 2 Executive SummaryBrowse Report : 3 Global Radiopharmaceuticals Market Overview3.1 Overview
  • 5. 3.2 Market Drivers3.2.1 Radiopharmaceutical-Based Cancer Therapy3.2.2 Growing Preference For Disease-Targeted Therapy3.2.3 Increasing Awareness Of Accurate Diagnosis3.2.4 Expanding Molecular Imaging Applications3.3 Market Restraints3.3.1 Strict Regulatory Guidelines For Production, Storage and Usage3.3.2 Worldwide Supply Shortages3.3.3 Price Sensitivity And Competitive Alternatives3.4 Market Opportunities3.4.1 Increasing Demand For Accurate Diagnosis and Treatment, Particularly InEmerging Markets3.4.2 Radiopharmaceutical-Based Personalized TherapyChapter 4 Market Definition & Supply Chain Analysis4.1 Market Definition4.2 Radiopharmaceutical Production : A Global Perspective4.3 Supply Chain AnalysisChapter 5 Global Radiopharmaceutical Generators Market5.1 Overview5.1.1 Global Radiopharmaceutical Generators Market, By Revenue, 2010-2018 (USDMillion)5.2 Mo-99/Tc-99m Generators5.3 Sr-82/Rb-82 Generators5.4 Ge-68/Ga-67,68 Generators5.5 Sr-90/Y-90 Generators5.6 W-188/Re-188 Generators
  • 6. Browse Report : 6 Global Radiopharmaceuticals Market, By End-User Groups6.1 Overview6.1.1 Global Radiopharmaceuticals Market By End Users, By Revenue, 2010-2018 (USDMillion)6.2 Hospitals and Medical Centers6.2.1 Global Radiopharmaceuticals Market By End User Groups : Hospitals and MedicalCentres, 2010 – 2018 (USD Million)6.3 Outpatient Diagnostic Centers6.3.1 Global Radiopharmaceuticals Market By End User Groups: Diagnostic Centres,2010 – 2018 (USD Million)Chapter 7 Global Radiopharmaceuticals Market, By Applications7.1 Overview7.2 Radiopharmaceuticals For Diagnosis7.2.1 Overview7.2.2 Radiopharmaceuticals For Diagnosis, By Technique7.2.2.1 Single-Photon Emission Computed Tomography (SPECT) Comparative Analysis: SPECT Radioisotopes Market, 2011 &2018 (%) Technetium (Tc-99m) Thallium (Tl-201) Gallium (Ga-67) Iodine (I-123) Rhenium (Re-186) Yttrium (Y-90) Others
  • 7. Positron Emission Tomography (PET) Comparative Analysis: PET Radioisotopes Market, 2011 & 2018(%) Fludeoxyglucose (18f-FDG) Rubidium (Rb-82) Others (Carbon-11 Choline, Nitrogen13 Ammonia)7.2.3 Radiopharmaceuticals For Diagnosis, By Indications7.2.3.1 Oncology7.2.3.2 Cardiovascular7.2.3.3 Others (Neurological, Thyroid, Gastrointestinal)7.3 Radiopharmaceuticals For Therapy7.3.1 Overview7.3.2 Oncology (Systemic Therapy) Comparative Analysis: Systemic Therapy Radioisotopes Market, 2011 &2018 (%) Iodine (I-131) Yttrium (Y-90) Samarium (Sm-153) Strontium (Sr-89) Rhenium (186Re) Lutetium-177 (Lu-177) Erbium-169 (169Er) Others7.3.3 Other Applications In Therapy (Cardiology, Neurology)7.4 TheranosticsBrowse Report : 8 Global Radiopharmaceuticals Market, By Geography
  • 8. 8.1 Overview8.2 North America8.2.1 North America Radiopharmaceuticals Market - Diagnosis and Systemic Therapy,2010-2018 (USD Million)8.2.2 North America Diagnosis Radiopharmaceuticals Market 2010-2018 (USD Million)8.3 Europe8.3.1 Europe Radiopharmaceuticals Market- Diagnosis and Systemic Therapy, 2010-2018 (USD Million)8.3.2 Europe Diagnosis Radiopharmaceuticals Market 2010-2018 (USD Million)8.4 Asia-Pacific (Apac)8.4.1 Asia-Pacific Radiopharmaceuticals Market- Diagnosis and Systemic Therapy, 2010-2018 (USD Million)8.4.2 Asia-Pacific Diagnosis Radiopharmaceuticals Market 2010-2018 (USD Million)8.5 Rest of the World (RoW)8.5.1 RoW Radiopharmaceuticals Market- Diagnosis and Systemic Therapy, 2010-2018(USD Million)8.5.2 RoW Diagnosis Radiopharmaceuticals Market 2010-2018 (USD Million)Chapter 9 Market Share Analysis By Key Players9.1 Radiopharmaceuticals Market9.2 Generators MarketBrowse Report : 10 Recommendations10.1 Identification and Elimination Of Barriers10.2 Development of Total Solutions10.3 Investing in Emerging Markets10.4 Entering Monopoly Markets
  • 9. Chapter 11 Company Profiles11.1 Cardinal Health Inc.11.1.1 Company Overview11.1.2 Financial Overview11.1.3 Business Strategies11.1.3.1 Mergers and Acquisitions11.1.3.2 External Funding11.1.3.3 Incorporation of Advanced Technologies to Support BusinessDevelopment11.1.4 Product Portfolio11.1.5 Recent Developments11.2 Covidien Plc11.2.1 Company Overview11.2.2 Product Portfolio11.2.3 Financial Overview11.2.4 Strategic Overview11.2.4.1 Mergers and Acquisitions11.2.4.2 Approvals11.2.5 Recent Developments11.3 GE Healthcare11.3.1 Company Overview11.3.2 Product Portfolio11.3.3 Financial Overview11.3.4 Strategic Overview11.3.4.1 Mergers and Acquisitions11.3.5 Recent Developments
  • 10. 11.4 IBA Group11.4.1 Company Overview11.4.2 Financial Overview11.4.3 Product Portfolio11.5 Lantheus Medical Imaging11.5.1 Company Overview11.5.2 Financial Overview11.5.3 Business Strategies11.5.3.1 Rigorous Research and Development Initiatives11.5.3.2 Selling Generic Products to Maintain Market Share11.5.4 Product Portfolio11.5.4.1 Recent Developments11.6 Monrol Nuclear Products, Inc.11.6.1 Company Overview11.6.2 Product Portfolio11.6.3 Strategic Overview11.6.3.1 Mergers and Acquisitions11.6.3.2 Collaborations11.6.4 Recent Developments11.7 Nordion, Inc.11.7.1 Company Overview11.7.2 Product Portfolio11.7.3 Financial Overview11.7.4 Strategic Overview11.7.4.1 Contracts and Agreements11.7.4.2 Divestiture11.7.5 Recent Developments
  • 11. New Product Launch11.8 NTP Radioisotopes (Pty) Ltd11.8.1 Company Overview11.8.2 Financial Overview11.8.3 Business Strategies11.8.3.1 Media Campaigns as a Brand Management Tool11.8.3.2 Business Expansion through Partnerships, Collaborations and Alliances11.8.4 Product Portfolio11.8.5 Recent Developments11.9 Polatom11.9.1 Company Overview11.9.2 Financial Overview11.9.3 Business Strategies11.9.3.1 Maintaining an Extensive Network of Distributors11.9.4 Product Portfolio11.9.5 Recent Developments11.10 Positron Corporation11.10.1 Company Overview11.10.2 Product Portfolio11.10.3 Financial Overview11.10.4 Strategic Overview11.10.4.1 Contracts and Agreements11.10.4.2 Collaborations11.10.5 Recent Developments11.10.5.1 Grants and Licenses11.10.5.2 Incentives11.11 Siemens Healthcare
  • 12. 11.11.1 Company Overview11.11.2 Financial Overview11.11.3 Business Strategies11.11.3.1 Investing In Emerging Economies11.11.3.2 Rigorous Research and Development Initiatives11.11.3.3 Identifying Key Growth Areas and Determining Short Term Goals(Agenda 2013) Maintaining An Extensive Suppliers Network11.11.4 Product Portfolio11.11.5 Recent DevelopmentsAbout Us:Transparency Market Research is a market intelligence company providing global businessinformation reports and services. Our exclusive blend of quantitative forecasting and trendsanalysis provides forward-looking insight for thousands of decision makers.We are privileged with highly experienced team of Analysts, Researchers and Consultants,who use proprietary data sources and various tools and techniques to gather, and analyzeinformation. Our business offerings represent the latest and the most reliable informationindispensable for businesses to sustain a competitive edge.Contact:Transparency Market Research90 State Street,Suite 700,AlbanyNY - 12207United StatesTel: +1-518-618-1030USA - Canada Toll Free 866-552-3453Email: sales@transparencymarketresearch.comWebsite: